News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. Reddy's Laboratories Ltd. (RDY) Completes Acquisition Of betapharm For 480 Million Euro



3/6/2006 11:48:55 AM

HYDERABAD, India--(BUSINESS WIRE)--March 4, 2006--Dr. Reddy's announced that it has completed the acquisition of 100% of betapharm Group, the fourth-largest generic pharmaceuticals company in Germany, for a total enterprise value of EUR 480 million in cash. Commenting, Satish Reddy, Chief Operating Officer, Dr. Reddy's Laboratories, said, "We have successfully completed the acquisition of betapharm. The strategic investment in betapharm is a step forward towards realizing Dr. Reddy's strategic intention of building a global generics business with strategic presence in all key markets."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES